Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. MicroPort CardioFlow Medtech's selling, general, & admin. expense for the
six
months ended in Dec. 2025 was $22.98 Mil.
Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Dec. 2025 was $39.46 Mil.
MicroPort CardioFlow Medtech (OTCPK:MROPF) Selling, General, & Admin. Expense Explanation
An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.
Warren Buffett likes companies with consistent SGA as the percentage of gross profit.
Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.
If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.
MicroPort CardioFlow Medtech Selling, General, & Admin. Expense Related Terms
MicroPort CardioFlow Medtech Selling, General, & Admin. Expense Historical Data
* Premium members only.
The historical data trend for MicroPort CardioFlow Medtech's Selling, General, & Admin. Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MicroPort CardioFlow Medtech Selling, General, & Admin. Expense Chart
MROPF vs ABT, SYK, MDT: Selling, General, & Admin. Expense Comparison
For the Medical Devices subindustry, MicroPort CardioFlow Medtech's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MicroPort CardioFlow Medtech Selling, General, & Admin. Expense vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MicroPort CardioFlow Medtech's Selling, General, & Admin. Expense distribution charts can be found below:
* The bar in red indicates where MicroPort CardioFlow Medtech's Selling, General, & Admin. Expense falls into.
MicroPort CardioFlow Medtech Selling, General, & Admin. Expense Calculation
Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.
Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $39.46 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Selling, General, & Admin. Expense of $39.46 Mil mean?
MicroPort CardioFlow Medtech (MROPF) has a Selling, General, & Admin. Expense of $39.46 Mil as of Dec. 2025. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on MicroPort CardioFlow Medtech and its competitors.
Is MicroPort CardioFlow Medtech's Selling, General, & Admin. Expense too high?
MicroPort CardioFlow Medtech's current Selling, General, & Admin. Expense is $39.46 Mil. Overall, MicroPort CardioFlow Medtech has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does MicroPort CardioFlow Medtech's Selling, General, & Admin. Expense compare to ABT and SYK?
MicroPort CardioFlow Medtech's Selling, General, & Admin. Expense of $39.46 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling, General, & Admin. Expense for a Medical Devices & Instruments company?
A good Selling, General, & Admin. Expense depends on the Medical Devices & Instruments industry context. However, Selling, General, & Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling, General, & Admin. Expense mean?
A high Selling, General, & Admin. Expense can signal that a stock is expensive relative to its fundamentals. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on MicroPort CardioFlow Medtech and its competitors. MicroPort CardioFlow Medtech's current Selling, General, & Admin. Expense is $39.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MicroPort CardioFlow Medtech stock overvalued right now?
MicroPort CardioFlow Medtech (MROPF) has a current Selling, General, & Admin. Expense of $39.46 Mil. The stock's GF Value™ is $3.23, compared to a current price of $0.65 — trading 80% below its estimated fair value. The current Selling, General, & Admin. Expense is $39.46 Mil. MicroPort CardioFlow Medtech's overall GF Score™ is 59/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling, General, & Admin. Expense calculated?
Selling, General, & Admin. Expense is calculated from a company's financial statements. For MicroPort CardioFlow Medtech (MROPF), the current Selling, General, & Admin. Expense is $39.46 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MicroPort CardioFlow Medtech (MROPF) Overvalued in 2026?
Based on GuruFocus' analysis, MicroPort CardioFlow Medtech stock appears to be undervalued.
The current stock price of $0.65 is trading 80% below its estimated GF Value™ of $3.23.
Key valuation signals for MROPF:
Selling, General, & Admin. Expense: $39.46 Mil
GF Value™: $3.23 vs. price of $0.65 (80% below fair value)
No single metric tells the full story. See the MROPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of VitaFlow, VitaFlow Liberty, Angelguide and AnchorMan. The Group derives revenue from the sales of medical devices through appointed distributors. It derives maximum revenue from PRC.
59GF Score
Get the complete analysis for MROPF
Selling, General, & Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MROPF has been successfully added to your 
